Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | Clinical applications of circulating tumor cells

Erin F. Cobain • 2 Jun 2020
ASCO 2020
Breast Cancer General

Erin F. Cobain, MD, of Rogel Cancer Center, Ann Arbor, MI, USA, highlights the importance of liquid biopsies as a less invasive approach for disease assesment, serial biopsies as well as the prognostic value of the presence of circulating tumour cells. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Erin F. Cobain

2:20
Management of patients with breast cancer during COVID-19
Erin F. Cobain • 2 Jun 2020
1:40
Unanswered questions in breast cancer
Erin F. Cobain • 2 Jun 2020
2:56
Breast cancer highlights from ASCO 2020
Erin F. Cobain • 2 Jun 2020
5:02
MI-ONCOSEQ: identifying pathogenic germline variants
Erin F. Cobain • 2 Jun 2020

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals